Shingles Vaccine May Reduce Cardiovascular Disease Risk by 9%

Recent research shows that the shingles vaccine may help reduce the risk of cardiovascular disease. A boy and the sea · E+/Getty A recent study found that the recombinant shingles vaccine (Shingrix) was associated with a 9% lower cardiov…
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by Healthline; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories

Why it mattersThe FDA announced a recall of saline and other IV fluids over possible contamination with fiberglass, stainless steel, and other hazardous materials. RicardoImagen/E+/Getty Images Two companies recalled saline and other …
The FDA announced a recall of saline and other IV fluids over possible contamination with fiberglass, stainless steel, and other hazardous materials. RicardoIma…

Why it mattersMs. Foundation For Women 2016 Gloria Awards Gala & After Party.
Ms. Foundation For Women 2016 Gloria Awards Gala & After Party. NEW YORK, NY – APRIL 27: Journalist, social and political activist Gloria Steinem spea…

Why it mattersRecent research shows that around 79% of young adults show signs of CKM. pixelfit · E+/Getty A recent study has found that around 79% of adults in their 20s already show signs of cardiovascular-kidney-metabolic (CKM) syn…
Recent research shows that around 79% of young adults show signs of CKM. pixelfit · E+/Getty A recent study has found that around 79% of adults in their 20s alr…

Why it mattersThe FDA approved Rasonque (daraxonrasib), a groundbreaking new drug to treat metastatic pancreatic cancer. Photo courtesy of Revolution Medicines The FDA approved Rasonque, a new drug to treat the most common type of pan…
The FDA approved Rasonque (daraxonrasib), a groundbreaking new drug to treat metastatic pancreatic cancer. Photo courtesy of Revolution Medicines The FDA approv…